- Home
- Publications
- Publication Search
- Publication Details
Title
HGF/MET Signaling in Malignant Brain Tumors
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 20, Pages 7546
Publisher
MDPI AG
Online
2020-10-14
DOI
10.3390/ijms21207546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 1 Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients With Advanced Solid Tumors
- (2020) John H Strickler et al. MOLECULAR CANCER THERAPEUTICS
- Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience
- (2020) Mohamed S. Abdelbaki et al. PEDIATRIC BLOOD & CANCER
- Brain tumors: Medulloblastoma, ATRT, ependymoma
- (2020) Sujith Baliga et al. PEDIATRIC BLOOD & CANCER
- MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling
- (2020) Ke Jiang et al. Cell Death & Disease
- Ultrasound-Mediated Drug Delivery in Cancer Therapy: A Review
- (2020) Nour M. Al Sawaftah et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- c-Met expression is a useful marker for prognosis prediction in IDH-mutant lower-grade gliomas and IDH-wildtype glioblastomas
- (2019) Shigeo Ohba et al. World Neurosurgery
- MET in glioma: signaling pathways and targeted therapies
- (2019) Fangling Cheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression
- (2019) Hyun Jung Kim et al. Frontiers in Oncology
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
- (2018) Lucia Demkova et al. Molecular Cancer
- MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
- (2018) Ying Zhang et al. Molecular Cancer
- Origin of Gliomas
- (2018) Sevin Turcan et al. SEMINARS IN NEUROLOGY
- Current Strategies for Brain Drug Delivery
- (2018) Xiaowei Dong Theranostics
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
- (2018) Huimin Hu et al. CELL
- HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers
- (2018) Hongli Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses
- (2017) Timothy Cloughesy et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
- (2017) Stephen C. Mack et al. NATURE
- Surgical oncology for gliomas: the state of the art
- (2017) Nader Sanai et al. Nature Reviews Clinical Oncology
- Understanding medulloblastoma
- (2017) Alyssa Quinlan et al. JAAPA-Journal of the American Academy of Physician Assistants
- Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment
- (2017) Benjamin Owusu et al. Cancers
- Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
- (2017) Nichola Cruickshanks et al. Cancers
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Imaging of oligodendroglioma
- (2016) Marion Smits BRITISH JOURNAL OF RADIOLOGY
- A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer
- (2016) Lee S. Rosen et al. CLINICAL CANCER RESEARCH
- Medulloblastoma
- (2016) Nathan E. Millard et al. JOURNAL OF CHILD NEUROLOGY
- Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma
- (2016) Emeline Tabouret et al. JOURNAL OF NEURO-ONCOLOGY
- In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models
- (2016) Paul E. Hughes et al. MOLECULAR CANCER THERAPEUTICS
- Biology and management of ependymomas
- (2016) Jing Wu et al. NEURO-ONCOLOGY
- Current and future strategies for treatment of glioma
- (2016) Nancy Ann Oberheim Bush et al. NEUROSURGICAL REVIEW
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Atypical teratoid/rhabdoid tumors: challenges and search for solutions
- (2016) Ahitagni Biswas et al. Cancer Management and Research
- Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein
- (2015) Anna C. Navis et al. ACTA NEUROPATHOLOGICA
- Oligodendroglioma: pathology, molecular mechanisms and markers
- (2015) Pieter Wesseling et al. ACTA NEUROPATHOLOGICA
- Comparative transcriptomics reveals similarities and differences between astrocytoma grades
- (2015) Michael Seifert et al. BMC CANCER
- Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor
- (2015) Tarun Garg et al. JOURNAL OF DRUG TARGETING
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma
- (2015) Mariska Sie et al. PLoS One
- The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme
- (2014) Lola B. Chambless et al. JOURNAL OF NEURO-ONCOLOGY
- Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011
- (2014) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors
- (2014) Kazumasa Odagiri et al. Radiation Oncology
- Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma
- (2014) Paul N. Kongkham et al. Translational Oncology
- Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
- (2013) Lin Cheng et al. CELL
- Gene silencing of c-Met leads to brain metastasis inhibitory effects
- (2013) Se Jeong Lee et al. CLINICAL & EXPERIMENTAL METASTASIS
- Hepatocyte Growth Factor Sensitizes Brain Tumors to c-MET Kinase Inhibition
- (2013) Y. Zhang et al. CLINICAL CANCER RESEARCH
- HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
- (2013) Shinya Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
- (2013) J. Jean Cui JOURNAL OF MEDICINAL CHEMISTRY
- Radiosensitization of brain metastasis by targeting c-MET
- (2013) Heekyoung Yang et al. LABORATORY INVESTIGATION
- Glioblastoma-Initiating Cells: Relationship with Neural Stem Cells and the Micro-Environment
- (2013) Nicolas Goffart et al. Cancers
- In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain Metastasis
- (2013) Avital Gaziel-Sovran et al. Frontiers in Oncology
- METGain in Diffuse Astrocytomas is Associated with Poorer Outcome
- (2012) Daniela Pierscianek et al. BRAIN PATHOLOGY
- Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
- (2012) Hua Mao et al. CANCER INVESTIGATION
- Medulloblastoma
- (2012) F. Bartlett et al. CLINICAL ONCOLOGY
- Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series
- (2012) Longbin Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
- (2012) N. J. Szerlip et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modern methods for delivery of drugs across the blood–brain barrier
- (2011) Yan Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3
- (2011) X. Liu et al. CLINICAL CANCER RESEARCH
- Hepatocyte growth factor twenty years on: Much more than a growth factor
- (2011) Takahiro Nakamura et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies
- (2011) D. B. Gursel et al. NEURO-ONCOLOGY
- c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
- (2011) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
- (2011) Neelesh Sharma et al. Therapeutic Advances in Medical Oncology
- Electromagnetic fields and the blood–brain barrier
- (2010) Rianne Stam BRAIN RESEARCH REVIEWS
- Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
- (2010) Filipa Lourenço Cardoso et al. BRAIN RESEARCH REVIEWS
- Safety, Pharmacokinetics, and Pharmacodynamics of AMG 102, a Fully Human Hepatocyte Growth Factor-Neutralizing Monoclonal Antibody, in a First-in-Human Study of Patients with Advanced Solid Tumors
- (2010) M. S. Gordon et al. CLINICAL CANCER RESEARCH
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine
- (2010) Toshikazu NAKAMURA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- The role of protein kinase C in the opening of blood–brain barrier induced by electromagnetic pulse
- (2010) Lian-Bo Qiu et al. TOXICOLOGY
- Astrocytes: biology and pathology
- (2009) Michael V. Sofroniew et al. ACTA NEUROPATHOLOGICA
- Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model
- (2009) Sheila Alcantara Llaguno et al. CANCER CELL
- c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration
- (2009) M. Provencal et al. CARCINOGENESIS
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
- (2009) J. P. Eder et al. CLINICAL CANCER RESEARCH
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ultrasound for drug and gene delivery to the brain
- (2008) Kullervo Hynynen ADVANCED DRUG DELIVERY REVIEWS
- Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor
- (2008) T. E. Reznik et al. MOLECULAR CANCER RESEARCH
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
- Progress and problems in the application of focused ultrasound for blood–brain barrier disruption
- (2008) Natalia Vykhodtseva et al. ULTRASONICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started